AnaptysBio, Inc. (ANAB)
66.11
-0.48
(-0.72%)
USD |
NASDAQ |
Apr 28, 16:00
66.15
+0.04
(+0.06%)
After-Hours: 07:20
AnaptysBio Research and Development Expense (TTM) : 135.41M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 109.27M |
| ADMA Biologics, Inc. | 4.761M |
| Nektar Therapeutics | 117.30M |
| Rigel Pharmaceuticals, Inc. | 33.30M |
| Axsome Therapeutics, Inc. | 182.48M |